NDC 50268-383-15
Immediate-release GUAIFENESIN 400 mg
50 Tablets (5 x 10) Unit Dose
5026838315
NDC 50268-383-15
Immediate-release GUAIFENESIN 400 mg
50 Tablets (5 x 10) Unit Dose
5026838315
EXPECTORANT
●Relieves Chest Congestion
●Thins and Loosens Mucus
OTC - PURPOSE SECTION
DRUG FACTS:
ACTIVE INGREDIENT
(Each immediate-release tablet) contains
Guaifenesin 400 mg........Expectorant
USES
•Helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive to rid the bronchial passageway of bothersome mucus.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
WARNINGS
Ask a doctor before use if you have
• Persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema.
• Cough accompanied by excessive phlegm (mucus)
When using this product
• do not exceed recommended dosage
• do not use for more than 7 days
INDICATIONS & USAGE SECTION
Stop use and ask a doctor if
• cough lasts for more than 7 days, recurs, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious condition.
WARNINGS SECTION
If pregnant or breast-feeding, ask a healthcare professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
DIRECTIONS
• adults and children 12 years of age and older: take 1 tablet every 4 hours with a full glass of water while symptoms persist. Do not exceed 6 doses in 24 hours.
• children under 12 years of age: do not use
OTHER INFORMATION
• store at 25ºC (77º) excursions permitted between 15º - 30ºC (59º - 86ºF)
• keep in a dry place and do not expose to excessive heat
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
